add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Top Life Science Companies in the Southeast Announced

October 8, 2009

Top Life Science Companies in the Southeast Announced

Filed under: SEBIO News — admin @ 3:31 pm

Atlanta, GA - Southeast BIO (SEBIO) announces the selection of the best life sciences deals in the Southeast, as determined by a Selection Committee comprised of regional and national venture capitalists. These companies, both early- and later-stage, will participate in the upcoming SEBIO Investor Forum being held on December 3-4, 2009 at the Charleston Place Hotel in Charleston, South Carolina.

“The economic environment has not dampened the biotech and medtech industries in the Southeast,” stated Stephen Snowdy, chair of the SEBIO selection committee and Partner with MB Venture Partners. “Once again, we had an outstanding group of opportunities from which to select this year’s SEBIO presentation line-up. That the Southeast is able to consistently provide these investors year in and year out with so many quality investment opportunities speaks highly of our research institutions, our entrepreneurs, and our entrepreneurial infrastructure in the Southeast.”

Those companies chosen for the Early-Stage event are seeking their first rounds of venture capital and/or angel investment. During the Investor Forum, the companies will participate in a mentoring session led by active early-stage investors. The Main Stage companies have generally completed at least one round of institutional financing and will each have the opportunity to make a ten-minute pitch to the full conference audience.

Visioneering Technologies Inc. (VTI) is one of many companies that has benefited from the Investor Forum. “VTI participated in SEBIO’s Early-Stage program in 2007,” said Joe DeLapp, CEO of VTI. “Through this program, we were privileged to have as one of our Early-Stage mentors MB Venture Partners, who along with 8 other financial institutions, gave VTI very valuable feedback. MB Venture Partners, in turn, recognized the tremendous potential of Visioneering Technologies’ optical designs, and led and syndicated our first round of venture capital funding in 2008 for .6 million, including funding from Charter Life Sciences, a top-tier firm in Palo Alto, California.”

Since 1996, companies that have participated in the SEBIO Investor Forum have raised over .5 billion in public and private offerings, making it the region’s most successful venue for linking industry investors with the Southeast’s top life sciences companies.

SEBIO 2009 Main Stage Companies
Altea Therapeutics Corporation, Atlanta, GA
Altor Bioscience Corporation, Miramar, FL
Arterain Medical, Atlanta, GA
CaloSyn Pharma, Inc., Shreveport, LA
Catena Pharmaceuticals, Inc., Durham, NC
EGEN, Inc., Huntsville, AL
GenerationOne, Inc., Miami, FL
MedShape Solutions, Inc., Atlanta, GA
NuMe, LLC, New Orleans, LA
Pathfinder Therapeautics, Inc., Nashville, TN
RetinaSense, LLC, Boca Raton, FL
Visioneering Technologies, Inc., Alpharetta, GA
Zirus, Inc., Buford, GA

SEBIO 2009 Early Stage Companies
Abeome Corporation, Athens, GA
AccuRx, Inc., Atlanta, GA
ArunA Biomedical, Inc., Athens, GA
Cerene Biomedics Inc., Durham, NC
DiscoveryBioMed, Inc., Birmingham, AL
EntoGenetics, Charlotte, NC
Heat Biologic, Miami Beach, FL
Immunologix, Inc., Charleston, SC
Ion Surgical Technologies, Inc., Mt. Pleasant, SC
Key Genomics, Charlottesville, VA
Ligamar, Inc., Chapel Hill, NC
MicroVide, Charleston, SC
Nelson Pharmaceuticals, LLC, Cary, NC
Phthisis Diagnostics, Charlottesville, VA
Synereca Pharmaceuticals, Chapel Hill, NC
X-Ray Robotics, Raleigh, NC

Register for the SEBIO Investor Forum before October 16th to take advantage of the early-bird registration rate:

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment